Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 52

Results For "safety"

1230 News Found

Menarini strengthens its presence in aesthetic dermatology in India
News | September 30, 2023

Menarini strengthens its presence in aesthetic dermatology in India

The introduction of 'Definisse Core Filler' is a testament to the company's premium scientific-based innovation


Biosergen, Alkem collaborate to develop anti-infective for severe fungal infections
News | September 26, 2023

Biosergen, Alkem collaborate to develop anti-infective for severe fungal infections

Biosergen AB is developing BSG005 for the treatment of severe and difficult-to-treat invasive fungal diseases


Briefs: Mankind Pharma and Sequent Scientific
News | September 26, 2023

Briefs: Mankind Pharma and Sequent Scientific

Mankind Pharma commences the commercial operations newly set-up plant in Udaipur


Eurofins opens BioPharma campus in Hyderabad
Biotech | September 25, 2023

Eurofins opens BioPharma campus in Hyderabad

The campus in Genome Valley will provide services in discovery chemistry & discovery biology, safety toxicology, bioanalytical services and formulation development to global pharmaceutical companies


Indraprastha Apollo Hospitals collaborates with MotoGP Bharat
News | September 25, 2023

Indraprastha Apollo Hospitals collaborates with MotoGP Bharat

The medical center at the Buddh International Circuit will be under the care of the Indraprastha Apollo Hospital team


Merck and Eisai update on Two Phase 3 Trials Evaluating Keytruda plus Lenima for cell lung cancer
Diagnostic Center | September 23, 2023

Merck and Eisai update on Two Phase 3 Trials Evaluating Keytruda plus Lenima for cell lung cancer

The companies will work with investigators to share the results with the scientific community


Biocon Biologics receives European Commission approval for biosimilar of Aflibercept ‘Yesafili’
Drug Approval | September 21, 2023

Biocon Biologics receives European Commission approval for biosimilar of Aflibercept ‘Yesafili’

The centralized marketing authorization granted by the EC is valid in all EU Member States as well as in the European Economic Area (EEA) countries Iceland, Liechtenstein and Norway


BioNTech and CEPI partnership to advance mRNA Mpox Vaccine development
Diagnostic Center | September 20, 2023

BioNTech and CEPI partnership to advance mRNA Mpox Vaccine development

The partnership is part of BioNTech’s strategy to develop novel prophylactic vaccines for the prevention of high-medical-need infectious diseases


Henkel joins MedTech Europe to drive innovation in the medical technology industry
News | September 20, 2023

Henkel joins MedTech Europe to drive innovation in the medical technology industry

Reinforces Henkel commitment to supporting customers and ecosystem in medical healthcare


CureVac highlights shift to mRNA technology in seasonal influenza vaccine development: GlobalData
Diagnostic Center | September 19, 2023

CureVac highlights shift to mRNA technology in seasonal influenza vaccine development: GlobalData

CureVac is among many pharmaceutical companies looking to produce a novel seasonal influenza vaccine via mRNA technology